Astellas Pharma Inc
F:YPHA
Wall Street
Price Targets
YPHA Price Targets Summary
Astellas Pharma Inc
According to Wall Street analysts, the average 1-year price target for
YPHA
is 11.61 EUR
with a low forecast of 8.2 EUR and a high forecast of 15.34 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is YPHA's stock price target?
Price Target
11.61
EUR
According to Wall Street analysts, the average 1-year price target for
YPHA
is 11.61 EUR
with a low forecast of 8.2 EUR and a high forecast of 15.34 EUR.
What is Astellas Pharma Inc's Revenue forecast?
Projected CAGR
1%
For the last 13 years the
compound annual growth rate for
Astellas Pharma Inc's revenue is
5%.
The projected
CAGR
for the next 3 years is
1%.
What is Astellas Pharma Inc's Operating Income forecast?
Projected CAGR
68%
For the last 13 years the
compound annual growth rate for
Astellas Pharma Inc's operating income is
5%.
The projected
CAGR
for the next 1 year is
68%.
What is Astellas Pharma Inc's Net Income forecast?
Projected CAGR
68%
For the last 13 years the
compound annual growth rate for
Astellas Pharma Inc's net income is
-3%.
The projected
CAGR
for the next 3 years is
68%.